ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Feb 6, 2012
Best Idea Astronics Up Nearly 8% Today on Strong Fourth-Quarter Results
Aerospace supplier Astronics reported excellent fourth-quarter results and provided an outlook that pleased most investors. We continue to believe the firm is a solid holding in the portfolio of our Best Ideas Newsletter.
Feb 2, 2012
Broadcom Pops 8% Today; The Firm's Shares Still Remain Undervalued
Last week, we highlighted Broadcom as undervalued. The shares popped 8% today on strong quarterly results and a better-than-expected outlook, and we think there is further upside to come based on valuation.
Feb 2, 2012
Amazon's Fourth-Quarter Earnings Leave Much to Be Desired
We don't think investors will be rewarded in Amazon's stock until it can demonstrate meaningful and sustainable earnings expansion.
Feb 1, 2012
Valuentum's February Edition of its Dividend Growth Newsletter!
The February edition of our Dividend Growth Newsletter is now available.
Feb 1, 2012
UPS Posts Solid Adjusted Fourth-Quarter Results; Sees Strong Package Delivery Growth in US
Economic bellwether UPS reported fourth-quarter results that reinforce our view that the US will avoid a double-dip recession despite the well-documented slowdown in Europe.
Feb 1, 2012
Pfizer, Eli Lilly Post Fourth-Quarter Results; Both Score High on Our Valuentum Dividend Cushion
Pfizer and Eli Lilly posted fourth-quarter results with each showing the impact of the industry's "patent cliff." Pfizer has lost exclusivity of Lipitor, while Eli Lilly is now facing competition for its blockbuster drug Zyprexa. Though their respective outlooks remain challenged, the safety of their current dividends remains excellent based on their respective Valuentum Dividend Cushion scores.
Jan 31, 2012
Helmerich & Payne Beats Expectations by $0.17, Beats on Revenues
Our Valuentum Buying Index (VBI) identifies stocks that are undervalued on both a discounted cash-flow basis and relative value basis and that are showing improving technical and momentum indicators. Helmerich & Payne, one of the few firms in our coverage universe that garners a top score on our index, blew by consensus expectations and is showing relative price outperformance today.
Jan 30, 2012
Reducing Our Fair Value Estimate on Fusion-iO on Lower Gross Margin Expectations
We've lowered our fair value estimate on one of the more revolutionary tech companies on the market today.
Jan 29, 2012
Honeywell Expects Strong 2012 Despite Downturn in Europe During First Half
Honeywell posted strong fourth-quarter results and noted that organic sales and earnings will expand in 2012 despite challenges in Europe. The industrial conglomerate continues to see strength across all four of its business segments.
Jan 29, 2012
Altria Posts Decent Fourth-Quarter Results; Dividend Yield Still Attractive
Altria posted fourth-quarter results that showed the firm retains significant pricing power. The company guided 2012 earnings higher, and we expect Altria's dividend payout to expand this year, offering investors a 6%+ yield at current prices.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.